Logo
Cedar Grove Capital Management
Search
Subscribe
Sign In
Home
Archive
Authors
Table of Contents
In the Press
Podcast
Our Fund
Contact Us
Oliver Buchannon
Paul Cerro

Former investment banker @MerrillLynch. Currently CIO of Cedar Grove Capital Management, a multi-strategy hedge fund.


LNSR Terminates Deal - Is It Worth More Than the $14/Share?

Mar 17, 2026

•

13 min read

LNSR Terminates Deal - Is It Worth More Than the $14/Share?

A quick walkthrough on the math post-deal break, and could LNSR still be compelling as a standalone company?

Understanding "Risk" From One of the Greats — Howard Marks

Mar 15, 2026

•

15 min read

Understanding "Risk" From One of the Greats — Howard Marks

What one of the best investors on Wall Street has to say about "risk" and what we can learn from it

NVO's Pressure Forces HIMS to Pivot

Mar 10, 2026

•

14 min read

NVO's Pressure Forces HIMS to Pivot

What both bulls and bears need to understand is the financial impact of HIMS pivoting hard from the compounded GLP-1 strategy

IPO Notes: Unprofitable Once Upon A Farm (OFRM) Goes Public

Mar 6, 2026

•

27 min read

IPO Notes: Unprofitable Once Upon A Farm (OFRM) Goes Public

Taking a look at the recent OFRM IPO, co-founded by actress Jennifer Garner, and why it could be an interesting setup for the newest CPG brand to hit the market

Quick Special Situation: Restaurant Take-Private w/ Potential Bidding War

Feb 16, 2026

•

8 min read

Quick Special Situation: Restaurant Take-Private w/ Potential Bidding War

Why this prized restaurant asset could strike up a bidding war amongst bidders looking to shore up their position in the quick service restaurant (QSR) space. Potential return could be in excess of 35%.

HIMS: Napoleon Watches Moscow Burn

Feb 9, 2026

•

24 min read

HIMS: Napoleon Watches Moscow Burn

Why we think Andrew's push deep into compounding GLP-1 land (Russia) has now reached its peak, and the drop is looking like quite the tumble.

🎙️ IC #9: Talking Telehealth and HIMS w/ Ashwin Sharma

Feb 4, 2026

•

6 min read

🎙️ IC #9: Talking Telehealth and HIMS w/ Ashwin Sharma

Our chat on all things telehealth and our views on HIMSwith our medical friend from across the pond

Special Situation: All Eyes on ABVX

Feb 4, 2026

•

19 min read

Special Situation: All Eyes on ABVX

Why we think this biotech trade, while popular, has limited downside risk in the event no suitor comes to scoop them up.

Quick Update - LE Gets A JV: +115% IRR // Trade Still In Play

Jan 27, 2026

•

8 min read

Quick Update - LE Gets A JV: +115% IRR // Trade Still In Play

Going over the announced LE joint venture by WHP and how there is still a trade on the table

Big Changes Coming To SNAP

Jan 20, 2026

•

5 min read

Big Changes Coming To SNAP

Why recent amendments to SNAP in 2026 could spell trouble for legacy CPG companies

[COTW] How A $1.5 Trillion Military Compares

Jan 11, 2026

•

5 min read

[COTW] How A $1.5 Trillion Military Compares

Why comparing a side-by-side of just how much the U.S. spends on defense is alarming

Fear-Based Investing - Part 2 // Future of Weapons Screening

Jan 5, 2026

•

34 min read

Fear-Based Investing - Part 2 // Future of Weapons Screening

Why a more dangerous everyday environment is allowing this stock to take advantage

🎙️ IC #8: Lessons From The Past

Dec 30, 2025

•

5 min read

🎙️ IC #8: Lessons From The Past

Sharing learning lessons from 2025 investments to not repeat them // HIMS, GENK, LQDA, REAL

Our 6 Investment Themes for 2026

Dec 22, 2025

•

4 min read

Our 6 Investment Themes for 2026

What we're looking at ahead of the next year, and why they matter

Fear-Based Investing - Part 1 // +226%

Dec 9, 2025

•

21 min read

Fear-Based Investing - Part 1 // +226%

An update on Owlet (OWLT) after a ~226% run-up

🎙️ IC #7: A Phoenix Rising From the Ashes - Talking Weight Watchers (WW) Post-Bankruptcy

Dec 2, 2025

•

5 min read

🎙️ IC #7: A Phoenix Rising From the Ashes - Talking Weight Watchers (WW) Post-Bankruptcy

An open discussion with David Helderman, Director of Investor Relations at WW International (WW)

IPO Notes: Gloo Holdings (GLOO) Nosebleed Valuation is Higher Than Heaven

Nov 19, 2025

•

27 min read

IPO Notes: Gloo Holdings (GLOO) Nosebleed Valuation is Higher Than Heaven

Why we think this new IPO is doomed to fail

Bunch of Quick Earnings Updates - Part II: (REAL, KITS, SNWV, LNSR)

Nov 13, 2025

•

25 min read

Bunch of Quick Earnings Updates - Part II: (REAL, KITS, SNWV, LNSR)

Going over earnings and our thoughts given updated information

Bunch of Quick Earnings Updates - Part I: (OSW, CPRI, WW, HIMS)

Nov 11, 2025

•

26 min read

Bunch of Quick Earnings Updates - Part I: (OSW, CPRI, WW, HIMS)

Going over earnings and our thoughts given updated information

WW: The Value Unlock is in the Credit Agreement

Oct 21, 2025

•

11 min read

WW: The Value Unlock is in the Credit Agreement

Why prioritizing deleveraging alone leads to unrealized equity appreciation

HIMS: Andrew Dudum. The "Teflon Don" of Telehealth

Oct 17, 2025

•

30 min read

HIMS: Andrew Dudum. The "Teflon Don" of Telehealth

Why time might be ticking for HIMS to continue exploiting its GLP-1 loophole

Quick Update: SNWV's Recent Pre-Announcement

Oct 7, 2025

•

11 min read

Quick Update: SNWV's Recent Pre-Announcement

Rehashing the math after lowering FY'25 guide

🎙️ IC #6: Talking Sanuwave Health (SNWV) w/Tenva Capital

Oct 2, 2025

•

4 min read

🎙️ IC #6: Talking Sanuwave Health (SNWV) w/Tenva Capital

An open discussion on the opportunity with SNWV

SNWV: A Med Devices Co. In Its Early Innings

Sep 22, 2025

•

6 min read

SNWV: A Med Devices Co. In Its Early Innings

Why we're bullish on Sanuwave Health, and why a post-Q2 earnings pullback makes for a compelling opportunity to potentially >2x

Why We're Excited About These New Situations: LNSR, PRPL, and LE

Sep 8, 2025

•

23 min read

Why We're Excited About These New Situations: LNSR, PRPL, and LE

An update on DKS/FL, LNSR and new ideas for PRPL and LE

Load more

Cedar Grove Capital Management

Multi-strategy equity research focused on L/S, M&A Arb, and other Special Situations.

© 2026 Cedar Grove Capital Management.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv